Skin-Like Electronics Paired with AI Could Become Game Changer in Health Monitoring and Diagnosis
By HospiMedica International staff writers Posted on 22 Nov 2022 |

Flexible, wearable electronics are making their way into everyday use, and their full potential is still to be realized. Soon, this technology could be used for precision medical sensors attached to the skin, designed to perform health monitoring and diagnosis. It would be like having a high-tech medical center at your instant beck and call. Worn routinely, future wearable electronics could potentially detect possible emerging health problems - such as heart disease, cancer or multiple sclerosis - even before obvious symptoms appear.
Such a skin-like device is being developed in a project between the U.S. Department of Energy’s (DOE) Argonne National Laboratory (Lemont, IL, USA) and the University of Chicago’s Pritzker School of Molecular Engineering (PME, Chicago, IL, USA). The device could also do a personalized analysis of the tracked health data while minimizing the need for its wireless transmission. Such a device would need to collect and process a vast amount of data, well above what even the best smartwatches can do today. And it would have to do this data crunching with very low power consumption in a very tiny space.
To address that need, the team called upon neuromorphic computing. This AI technology mimics operation of the brain by training on past data sets and learning from experience. Its advantages include compatibility with stretchable material, lower energy consumption and faster speed than other types of AI. The other major challenge the team faced was integrating the electronics into a skin-like stretchable material. The key material in any electronic device is a semiconductor. In current rigid electronics used in cell phones and computers, this is normally a solid silicon chip. Stretchable electronics require that the semiconductor be a highly flexible material that is still able to conduct electricity.
The team’s skin-like neuromorphic “chip” consists of a thin film of a plastic semiconductor combined with stretchable gold nanowire electrodes. Even when stretched to twice its normal size, their device functioned as planned without formation of any cracks. As one test, the team built an AI device and trained it to distinguish healthy electrocardiogram (ECG) signals from four different signals indicating health problems. After training, the device was more than 95% effective at correctly identifying the ECG signals. The plastic semiconductor also underwent analysis on beamline 8-ID-E at the Advanced Photon Source (APS), a DOE Office of Science user facility at Argonne. Exposure to an intense X-ray beam revealed how the molecules that make up the skin-like device material reorganize upon doubling in length. These results provided molecular level information to better understand the material properties.
“The planned upgrade of the APS will increase the brightness of its X-ray beams by up to 500 times,” said Joe Strzalka, an Argonne physicist. “We look forward to studying the device material under its regular operating conditions, interacting with charged particles and changing electrical potential in its environment. Instead of a snapshot, we’ll have more of a movie of the structural response of the material at the molecular level.” The greater beamline brightness and better detectors will make it possible to measure how soft or hard the material becomes in response to environmental influences.
“While still requiring further development on several fronts, our device could be a game changer in which everyone can get their health status in a much more effective and frequent way,” added Sihong Wang, assistant professor in UChicago’s PME with joint appointment in Argonne’s Nanoscience and Technology division. “While still requiring further development on several fronts, our device could one day be a game changer in which everyone can get their health status in a much more effective and frequent way.”
Related Links:
Argonne National Laboratory
PME
Channels
Critical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more